Clinical Trial Update: An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN [Phase 3]

View source ↗

Summary

An extension Phase 3 study of BCD-148 in patients with paroxysmal nocturnal hemoglobinuria (PNH) who previously participated in BCD-148-2/NOCTURN has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• BCD-148

Snippet

Sponsor: Biocad | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 3 | Status: COMPLETED